- Conditions
- Osteoarthritis
- Interventions
- RN624 (PF-04383119), placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 40 Years to 75 Years
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 48
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 42 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 35
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Osteoarthritis
- Interventions
- tanezumab
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 2,147 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 226
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Huntsville, Alabama + 148 more
- Conditions
- Diabetic Peripheral Neuropathy
- Interventions
- Tanezumab, placebo
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 48
- States / cities
- Mobile, Alabama • Goodyear, Arizona • Litchfield Park, Arizona + 34 more
- Conditions
- Osteoarthritis, Arthritis, Pain
- Interventions
- Placebo IV, Placebo SC, Tanezumab SC, Tanezumab IV
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 385 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 91
- States / cities
- Montgomery, Alabama • Mesa, Arizona • Phoenix, Arizona + 64 more
- Conditions
- Cystitis, Interstitial
- Interventions
- PF-04383119, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 34
- States / cities
- Peoria, Arizona • Fresno, California • Glendora, California + 25 more
- Conditions
- Low Back Pain
- Interventions
- Tanezumab 20 mg, Tanezumab 10 mg
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 849 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 149
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Hueytown, Alabama + 99 more
- Conditions
- Osteoarthritis, Knee, Osteoarthritis, Hip
- Interventions
- Placebo, Tanezumab 2.5 mg, Tanezumab 2.5mg/5mg
- Other · Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 698 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 68
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Surprise, Arizona + 54 more
- Conditions
- Osteoarthritis
- Interventions
- Tanezumab, Placebo
- Biological · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 18
- States / cities
- Atlantis, Florida • Fort Myers, Florida • South Miami, Florida + 6 more
- Conditions
- Schwannomatosis, Pain
- Interventions
- Tanezumab, Placebo
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Osteoarthritis
- Interventions
- tanezumab, Placebo
- Biological · Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 97
- States / cities
- Jonesboro, Arkansas • Aurora, Colorado • Centennial, Colorado + 42 more
- Conditions
- Arthritis, Osteoarthritis, Osteoarthritis, Hip
- Interventions
- tanezumab, Placebo
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 627 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 99
- States / cities
- Mobile, Alabama • Paradise Valley, Arizona • Peoria, Arizona + 74 more
- Conditions
- Osteoarthritis, Arthritis
- Interventions
- NSAID, tanezumab
- Drug · Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 2,720 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 250
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 161 more
- Conditions
- Endometriosis
- Interventions
- Tanezumab, Placebo
- Biological · Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 30
- States / cities
- Mobile, Alabama • Tucson, Arizona • San Diego, California + 20 more
- Conditions
- Osteoarthritis, OA Knee Pain, Arthritis
- Interventions
- RN624 (PF-04383119)
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 40 Years to 75 Years
- Enrollment
- 287 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 36
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Anaheim, California + 24 more
- Conditions
- Chronic Pain, Osteoarthritis, Hip, Osteoarthritis, Knee
- Interventions
- NSAID, Tanezumab 2.5 mg, Tanezumab 5 mg
- Drug · Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 3,021 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2019
- U.S. locations
- 299
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 187 more
- Conditions
- Neoplasms, Bone Metastases
- Interventions
- Anti-NGF AB
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 6
- States / cities
- La Jolla, California • Shreveport, Louisiana • Salt Lake City, Utah
- Conditions
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome
- Interventions
- Tanezumab, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 62 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Goodyear, Arizona • Litchfield Park, Arizona + 17 more
- Conditions
- Low Back Pain
- Interventions
- Placebo to Week 16; tanezumab 5mg SC, Placebo to Week 16, tanezumab 10 mg SC, Tanezumab 5 mg SC, Tanezumab 10 mg SC, Tramadol PR oral
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,832 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 179
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Saraland, Alabama + 124 more
- Conditions
- Low Back Pain
- Interventions
- Naproxen, Placebo, PF-04383119 (RN624)
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 38
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Chandler, Arizona + 30 more
- Conditions
- Osteoarthritis, Knee, Osteoarthritis, Hip
- Interventions
- Tanezumab 2.5 mg, Tanezumab 5 mg, Tanezumab 10 mg
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 679 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 100
- States / cities
- Mobile, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 70 more
- Conditions
- Healthy Volunteers
- Interventions
- tanezumab
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 76 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 1
- States / cities
- Cypress, California
- Conditions
- Neoplasm Metastasis, Palliative Care
- Interventions
- Tanezumab 10 mg IV, IV Placebo for tanezumab
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 59 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 12
- States / cities
- La Jolla, California • South Bend, Indiana • Shreveport, Louisiana + 2 more
- Conditions
- Osteoarthritis
- Interventions
- Tanezumab
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- La Mesa, California
- Conditions
- Arthritis, Osteoarthritis
- Interventions
- tanezumab, Placebo
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 697 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 82
- States / cities
- Phoenix, Arizona • Danbury, Connecticut • Stamford, Connecticut + 65 more